Russia’s coronavirus vaccine Sputnik V has been authorized in Montenegro and Saint Vincent and the Grenadines, thus bringing the total number of countries where it is authorized to 26, the Russian Direct Investment Fund (RDIF) said Friday, as reported by Sputnik News.
“The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of Russia’s Sputnik V vaccine against coronavirus in Montenegro and Saint Vincent and the Grenadines. In total, 26 countries have already authorised Sputnik V,” the RDIF said in a press release.
This means that Sputnik is “one of the world’s top three coronavirus vaccines in terms of the number of approvals issued by government regulators,” the press release continued.
Earlier this month, peer-reviewed medical journal The Lancet published an interim analysis from the phase III trials of the Sputnik V vaccine, showing its 91.6 percent efficacy against symptomatic COVID-19.
Russia’s Sputnik V is the world’s first vaccine against COVID-19 and was developed by the Gamaleya Research Institute of Epidemiology and Microbiology and registered on 11 August.
Sputnik V uses two different vectors for the two-shot vaccination course, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.